01.05.2004
Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (`Iressa', ZD1839)
Erschienen in: Clinical & Experimental Metastasis | Ausgabe 3/2004
Einloggen, um Zugang zu erhalten